Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid for the Prevention of Blood Loss After Vaginal Delivery in a High Risk Pregnancy: A Double Blind Randomized Controlled Trial

NCT04201951 is registered in ClinicalTrials.gov with Hawler Medical University as lead sponsor.

NCT NCT04201951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04201951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid for the Prevention of Blood Loss After Vaginal Delivery in a High Risk Pregnancy: A Double Blind Randomized Controlled Trial
Lead sponsor
Hawler Medical University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2020
Completion date
October 10, 2020
Enrollment
196 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

high risk pregnancy, postpartum hemorrhage, third-stage postpartum hemorrhage, with delivery, tranexamic acid